Spatiotemporal effects of IL-4 and designed novel compounds on CNS repair during neu-roinflammation

B15

Nervous tissue regeneration is still an unmet need in Multiple Sclerosis (MS). Our latest discovery of a direct neuronal interleukin-4 (IL-4) receptor signalling pathway, leading to axonal protection and repair during chronic neuroinflammation, set the stage for this proposal. We plan to unravel the en-dogenous source and novel functions of IL-4 and develop our discovery for transfer into the clinic. We designed novel compounds, which we would like to test in different MS models, compare and combine with other treatments, and study in human culture systems to directly unravel regenerative effects on human neurons and test blood brain barrier permeability. The aim is that results from these investigations lead to novel insights into neuroprotection and -regeneration and to clinical translation of our compounds. These questions will be elucidated in more detail:

    1. What is the source and what are the novel functions of IL-4 in the CNS?
    2. How can we translate IL-4 therapy to the clinic? For this purpose we will use in-house designed novel compounds?
    3. How do the compounds act on human neurons? Are they able to cross the blood brain barrier?

Principal Investigators:

Dr. rer. nat. Christina Francisca Vogelaar
Klinik für Neurologie
Mainz
tineke.vogelaar@unimedizin-mainz.de

Univ.-Prof. Dr. med. Frauke Zipp
Klinik für Neurologie
Mainz
frauke.zipp@unimedizin-mainz.de

News

Thu, 15/09/2022
Photo gallery: Inflammation & Imaging Symposium in the MIC building
Muenster. From September 12th to 14th scientists from Muenster University and their international guests discussed the latest developments in research on inflammation and the imaging of the immune system at the 2nd Inflammation & Imaging Symposium. The annual event is jointly organised by several research networks from Münster, among them the CRC/TRR 128 “Multiple Sclerosis”. […]...more
Tue, 28/06/2022
CRC Retreat in Münster
Muenster. After a long pause, more than 90 participants of the CRC joined in Muenster Factory Hotel to update on the latest developments. We heard the most recent on a selection of the CRC projects and there was also plenty of time for fruitful discussion and socializing in the evening....more
Mon, 23/05/2022
EU Research Council awards Lydia Sorokin Advanced Grant
Münster – The biochemist and Principal investigator of the CRC 128 Prof. Dr. Lydia Sorokin has received the coveted “Advanced Grant” awarded by the European Research Council (ERC). The funding of ca. 2.3 million euros enables the realisation of outstanding research projects. Lydia Sorokin heads the Institute for Physiological Chemistry and Pathobiochemistry at Muenster University. […]...more